The Pre-POCT-Non-Conveyance Trial: Prehospital Point-of-Care Testing to Support Non-Conveyance Decisions

Many adults assessed by ambulance services are transported to hospital but discharged shortly after arrival without requiring advanced diagnostic testing or treatment. These potentially avoidable admissions contribute to emergency department crowding and increased healthcare utilization. Improving prehospital decision-making may reduce unnecessary hospital transports while maintaining patient safety. This study evaluates whether rapid point-of-care blood testing performed by ambulance clinicians can be implemented in routine prehospital assessment and support more informed decisions regarding hospital conveyance following an emergency call.

This is a prospective, matched, parallel, cluster-randomized trial conducted within the Prehospital Emergency Medical Services (EMS) of the Central Denmark Region, Denmark. Ten ambulance clusters are included and allocated in a 1:1 ratio to either an intervention strategy integrating point-of-care testing (POCT) into the prehospital assessment or to standard care. Prior to randomization, clusters are matched in pairs based on their historical non-conveyance rate during the preceding six months, overall case volume, and geographic characteristics to ensure balance in baseline practice patterns and workload and to reduce between-cluster heterogeneity. Each matched pair is then randomized to either the intervention or control group.

Participants are adults attended by participating ambulance clusters following an emergency call or GP-commissioned ambulance dispatch through the Emergency Medical Dispatch Centre (EMDC). In the intervention clusters, POCT may be performed in clinically stable patients who would otherwise be considered for hospital conveyance based on the initial on-scene ambulance assessment.

The intervention consists of on-scene biochemical testing using portable POCT devices. The iSTAT Alinity system with CHEM8+ cartridges measures sodium, potassium, chloride, calcium, urea, creatinine, glucose, and total carbon dioxide. QuickRead go is used to measure C-reactive protein and hemoglobin, and HemoCue WBC DIFF is used to measure leukocyte count. Control clusters follow existing assessment procedures without access to POCT. Apart from access to POCT devices and results, all other aspects of clinical management follow standard regional EMS practice.

The primary objective is to evaluate whether prehospital POCT can be implemented in routine ambulance-based assessment. The primary outcome is implementation of prehospital POCT, defined as the proportion of intervention-cluster attended patient encounters within the study population in which POCT was attempted, at least one valid POCT result was obtained and documented, and the result was available before the final conveyance decision.

Non-conveyance is retained as a key secondary clinical outcome and will be compared between randomized intervention and control clusters according to the intention-to-treat principle. Safety and clinical outcomes include hospital admission within 24 hours among non-conveyed patients, short-stay hospitalization, total hospital length of stay, intensive care unit admission, and 30-day mortality.

The trial is not powered to detect definitive differences in non-conveyance or safety outcomes. Instead, it is designed to estimate key implementation parameters, including the proportion of attended patient encounters in which POCT is attempted, the proportion of attempts yielding a valid result, documentation completeness, and availability of POCT results before the final conveyance decision. Clinical outcomes will be interpreted as secondary and exploratory and used to inform the design of a future definitive effectiveness trial.

Ethics and regulatory oversight:

The study has been assessed by the Central Denmark Region Committees on Health Research Ethics (Denmark) and determined not to constitute a health research study under Danish legislation (Consolidation Act on Research Ethics Review of Health Research Projects, Section 2(1)). Therefore, the study does not require approval from a research ethics committee, and formal ethics approval was not obtained.

In accordance with this determination, individual informed consent is not required, as the study is conducted at the cluster level within routine care without alteration of standard treatment pathways beyond the availability of point-of-care testing.

All data are handled in compliance with applicable data protection regulations. The determination is documented in a formal written statement from the Central Denmark Region Committees on Health Research Ethics. This documentation is included as an appendix to the Statistical Analysis Plan. No biological samples are stored for research purposes beyond immediate clinical analysis.